Literature DB >> 7503594

Postmenopausal virilization due to ovarian hyperthecosis.

T Agorastos1, N Argyriadis, G Fraggidis, A Vakiani, V Zournatzi, J Bontis.   

Abstract

A case of a 66-year-old obese woman with type II diabetes mellitus and a 4 year history of virilism is presented. After removal of the ovaries the raised testosterone levels returned to normal and signs of virilism gradually receded. The histological finding of nodular hyperthecosis of the ovaries is discussed in relation to hyperinsulinaemia.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7503594     DOI： 10.1007/bf00634494

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN： 0932-0067            Impact factor:   2.344


  5 in total

Review 1.  Insulin-like growth factors and thecal-granulosa-cell function.

Authors:  F Geisthovel; I Moretti-Rojas; F J Rojas; R H Asch
Journal:  Hum Reprod       Date:  1990-10       Impact factor: 6.918

Review 2.  Hirsutism, its pathogenesis.

Authors:  M Breckwoldt; H P Zahradnik; P Wieacker
Journal:  Hum Reprod       Date:  1989-08       Impact factor: 6.918

3.  Virilizing stromal thecosis of the ovary associated with multiple corpora atretica.

Authors:  G J Nuovo
Journal:  Am J Clin Pathol       Date:  1989-10       Impact factor: 2.493

4.  Postmenopausal hyperandrogenism of ovarian origin. A clinicopathologic study of four cases.

Authors:  L H Honoré; R Chari; H D Mueller; D C Cumming; J Z Scott
Journal:  Gynecol Obstet Invest       Date:  1992       Impact factor: 2.031

5.  Hyperinsulinemia in hyperthecosis of the ovaries.

Authors:  M Nagamani; T Van Dinh; M E Kelver
Journal:  Am J Obstet Gynecol       Date:  1986-02       Impact factor: 8.661
  5 in total
  1 in total

1.  Acute goserelin administration inhibits gonadotropin and androgen secretion in post-menopausal women with ovarian hyperandrogenism.

Authors:  C Di Bisceglie; L Brocato; M Tagliabue; A Bertagna; L Gianotti; E Ghigo; C Manieri
Journal:  J Endocrinol Invest       Date:  2003-03       Impact factor: 4.256
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.